Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Unknown 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 6Thoracic 3Head & Neck 2Gynecologic 2Breast 2Lymphoid 1Genitourinary 1Dermatologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 234Head and Neck Neoplasms 123Carcinoma, Non-Small-Cell Lung 78Melanoma 73Colorectal Neoplasms 43Carcinoma, Renal Cell 43Neoplasm Metastasis 35Neoplasms 33Triple Negative Breast Neoplasms 31Uterine Cervical Neoplasms 30Stomach Neoplasms 30Carcinoma, Transitional Cell 30Breast Neoplasms 30Lung Neoplasms 29Ovarian Neoplasms 28Carcinoma, Squamous Cell 24Pancreatic Neoplasms 23Carcinoma 23Esophageal Neoplasms 20Endometrial Neoplasms 19Oropharyngeal Neoplasms 18Mouth Neoplasms 18Carcinoma, Hepatocellular 18Small Cell Lung Carcinoma 17Parkinson Disease 4, Autosomal Dominant Lewy Body 16Urinary Bladder Neoplasms 13Nasopharyngeal Carcinoma 13Laryngeal Neoplasms 13Prostatic Neoplasms 12Mesothelioma 12

Interventions

Surveys and Questionnaires 4Nivolumab 3pembrolizumab 2cemiplimab 2atezolizumab 2amminedichloro(2-methylpyridine)platinum(II) 2Blood Specimen Collection 2trastuzumab deruxtecan 1trametinib 1repotrectinib 1pralsetinib 1pazopanib 1motexafin gadolinium 1durvalumab 1dabrafenib 1avelumab 1alectinib 1Transurethral Resection of Prostate 1Tomography, X-Ray Computed 1Reverse Transcriptase Polymerase Chain Reaction 1Radiosurgery 1Quality of Life 1Patient-Specific Modeling 1Oncolytic Virotherapy 1Ocoxin 1Observation 1Mass Screening 1MLN 8237 1Immune Checkpoint Inhibitors 1Hyperspectral Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Gastrointestinal Neoplasms × pembrolizumab × Head & Neck × Clear all
NCT03329950 2024-03-28

A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

Celldex Therapeutics

Phase 1 Completed
132 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidThoracic

Bile Duct Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Esophageal Neoplasms, Fallopian Tube Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Laryngeal Neoplasms, Liver Neoplasms, Lung Neoplasms, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Melanoma, Mouth Neoplasms, Oropharyngeal Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Lymphoma, Large B-Cell, Diffuse, Cholangiocarcinoma, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Hyper-IgM Immunodeficiency Syndrome

NCT04460456 2022-06-30

A Study of SBT6050 Alone and in Combination With PD-1 Inhibitors in Subjects With Advanced HER2 Expressing Solid Tumors

Silverback Therapeutics

Phase 1 Unknown
58 enrolled
BreastGastrointestinalGynecologicHead & NeckThoracic

Biliary Tract Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡